Apokyn for Motor IMProvement of Morning AKinesia Trial (AM IMPAKT)

Clinical trial NCT01770145 · COMPLETED

Trial details

NCT number: NCT01770145
Sponsor: MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Parkinson's Disease Motor Symptoms Akinesia Hypomobility Delayed Levodopa Onset

Start date: 2012-12-01
Primary completion: 2014-04-01
Enrollment: 127

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.